Mental Disorders

Daytime Light Exposure Linked to Lower Dementia Risk

Higher daytime light exposure was associated with a significantly lower risk of developing dementia, while nighttime light exposure showed no significant relationship. In this study of 87,577 dementia-free UK adults (average age 62 years) followed for a median of 8.1 years, 741 participants developed dementia. Researchers measured light exposure using wrist-worn devices over seven days and found that exposure to daytime light levels above 1,000 lux was associated with a 16% lower risk of dementia. Spending at least 0.7 hours per day in bright light (≥5,000 lux) was linked to an even greater risk reduction of about 17%. Exploratory analyses suggested that healthier circadian rest–activity rhythms and favorable brain structural changes may explain up to one-third of this protective association. The benefits of daytime light exposure were particularly strong among high risk individuals with high nighttime light exposure, an evening chronotype (night owl), or the APOE ε4 genetic risk variant, with dementia risk reductions reaching as much as 41%. Notably, insufficient bright daytime light exposure (<0.7 hours/day) predicted dementia risk more strongly than several established risk factors, including obesity, alcohol consumption, and traumatic brain injury. These findings suggest that increasing exposure to natural daylight may represent a simple, low-cost strategy for supporting long-term brain health and reducing dementia risk. Source: https://onlinelibrary.wiley.com/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.